Evaluation of the effects of chitosan-loaded Curcumin-Vancomycin nanoparticles on biofilm formation in Staphylococcus aureus

Mohammad Amin  Mohammadi; Zahra  Keshtmand

doi:10.66224/jcbior.7.3.358

Authors

Mohammad Amin Mohammadi Department of Biology, CT.C., Islamic Azad University, Tehran, Iran
Zahra Keshtmand Department of Biology, CT.C., Islamic Azad University, Tehran, Iran https://orcid.org/0000-0002-9759-1446

DOI:

https://doi.org/10.66224/jcbior.7.3.358

Keywords:

Staphylococcus aureus, Biofilms, Chitosan, Curcumin, Vancomycin

Abstract

Staphylococcus aureus is a major opportunistic pathogen responsible for persistent and device-related infections, largely due to its strong biofilm-forming capacity and increasing antimicrobial resistance. This study aimed to evaluate the antibiofilm effects of chitosan-loaded curcumin-vancomycin nanoparticles against S. aureus clinical isolates. Nanoparticles were synthesized via ionic gelation and characterized using dynamic light scattering and electrophoretic light scattering techniques. Biofilm formation was quantified using the crystal violet microtiter plate assay, and gene expression analysis of the icaA gene was performed in biofilm-producing S. aureus exposed to sub-minimum inhibitory concentration (MIC) concentrations of nanoparticles using real-time PCR and the 2^-ΔΔCt method. Results showed a significant reduction in icaA expression following treatment with curcumin, vancomycin, and particularly curcumin-vancomycin-loaded chitosan nanoparticles compared to untreated controls (P <0.05). The greatest suppression of icaA expression was observed in the nanoparticle-treated group, indicating enhanced antibiofilm activity. The mean hydrodynamic diameter was 333.8 ± 9.2 nm with a polydispersity index (PDI) of 0.236, indicating a relatively uniform size distribution. The zeta potential was +28.9 mV, confirming good colloidal stability. All tested isolates were strong biofilm producers. MIC of nanoparticles ranged from 64 to 256 µg/mL, demonstrating strain-dependent antimicrobial activity. The findings demonstrate that curcumin-vancomycin-loaded chitosan nanoparticles effectively inhibit biofilm formation and downregulate key biofilm-associated genes in S. aureus. This synergistic nano-formulation offers a promising strategy for overcoming biofilm-associated infections and improving the efficacy of conventional antibiotics.

References

1. Schilcher K, Horswill AR. Staphylococcal Biofilm Development: Structure, Regulation, and Treatment Strategies. Microbiol Mol Biol Rev. 2020;84(3):e00026-19.

DOI: 10.1128/MMBR.00026-19 PMID: 32792334

2. Agbo MC, Ezeonu IM, Onodagu BO, Ezeh CC, Ozioko CA, Emencheta SC. Antimicrobial resistance markers distribution in Staphylococcus aureus from Nsukka, Nigeria. BMC Infect Dis. 2024;24(1):320.

DOI: 10.1186/s12879-024-09126-1 PMID: 38491352

3. Idrees M, Sawant S, Karodia N, Rahman A. Staphylococcus aureus Biofilm: Morphology, Genetics, Pathogenesis and Treatment Strategies. Int J Environ Res Public Health. 2021;18(14):7602.

DOI: 10.3390/ijerph18147602 PMID: 34300053

4. Seethalakshmi PS, Rajeev R, Kiran GS, Selvin J. Promising treatment strategies to combat Staphylococcus aureus biofilm infections: an updated review. Biofouling. 2020;36(10):1159-1181. DOI: 10.1080/08927014.2020.1857743 PMID: 33353409

5. Tuon FF, Suss PH, Telles JP, Dantas LR, Borges NH, Ribeiro VST. Antimicrobial Treatment of Staphylococcus aureus Biofilms. Antibiotics (Basel). 2023;12(1):87.

DOI: 10.3390/antibiotics12010087 PMID: 36671287

6. Nasser A, Dallal MMS, Jahanbakhshi S, Azimi T, Nikouei L. Staphylococcus aureus: Biofilm Formation and Strategies Against it. Curr Pharm Biotechnol. 2022;23(5):664-678.

DOI: 10.2174/1389201022666210708171123 PMID: 34238148

7. Guo N, Bai X, Shen Y, Zhang T. Target-based screening for natural products against Staphylococcus aureus biofilms. Crit Rev Food Sci Nutr. 2023;63(14):2216-2230.

DOI: 10.1080/10408398.2021.1972280 PMID: 34491124

8. Zheng D, Huang C, Huang H, Zhao Y, Khan MRU, Zhao H, et al. Antibacterial Mechanism of Curcumin: A Review. Chem Biodivers. 2020;17(8):e2000171. DOI: 10.1002/cbdv.202000171 PMID: 32533635

9. Gao K, Zhang B, Zhao F. Antibiofilm Effect of Curcumin Against Staphylococcus aureus Surface Wound Biofilm-Associated Infection: In Vitro and In Silico. Appl Biochem Biotechnol. 2023;195(9):5329-5337.

DOI: 10.1007/s12010-022-03844-5 PMID: 35166997

10. Batista de Andrade Neto J, Pessoa de Farias Cabral V, Brito Nogueira LF, Rocha da Silva C, Gurgel do Amaral Valente Sá L, Ramos da Silva A, et al. Anti-MRSA activity of curcumin in planktonic cells and biofilms and determination of possible action mechanisms. Microb Pathog. 2021;155:104892.

DOI: 10.1016/j.micpath.2021.104892 PMID: 33894289

11. Ma S, Moser D, Han F, Leonhard M, Schneider-Stickler B, Tan Y. Preparation and antibiofilm studies of curcumin loaded chitosan nanoparticles against polymicrobial biofilms of Candida albicans and Staphylococcus aureus. Carbohydr Polym. 2020;241:116254.

DOI: 10.1016/j.carbpol.2020.116254 PMID: 32507182

12. Pamukçu A, Erdoğan N, Şen Karaman D. Polyethylenimine-grafted mesoporous silica nanocarriers markedly enhance the bactericidal effect of curcumin against Staphylococcus aureus biofilm. J Biomed Mater Res B Appl Biomater. 2022;110(11):2506-2520.

DOI: 10.1002/jbm.b.35108 PMID: 35735075

13. Xu J, Lin Q, Sheng M, Ding T, Li B, Gao Y, et al. Antibiofilm Effect of Cinnamaldehyde-Chitosan Nanoparticles against the Biofilm of Staphylococcus aureus. Antibiotics (Basel). 2022;11(10):1403.

DOI: 10.3390/antibiotics11101403 PMID: 36290061

14. Zhang Z, Chen J, Zou L, Tang J, Zheng J, Luo M, et al. Preparation, Characterization, and Staphylococcus aureus Biofilm Elimination Effect of Baicalein-Loaded β-Cyclodextrin-Grafted Chitosan Nanoparticles. Int J Nanomedicine. 2022;17:5287-5302.

DOI: 10.2147/IJN.S383182 PMID: 36411767

15. Rashki S, Safardoust-Hojaghan H, Mirzaei H, Abdulsahib WK, Mahdi MA, Salavati-Niasari M, et al. Delivery LL37 by chitosan nanoparticles for enhanced antibacterial and antibiofilm efficacy. Carbohydr Polym. 2022;291:119634.

DOI: 10.1016/j.carbpol.2022.119634 PMID: 35698353

16. Etemadi S, Barhaghi MHS, Leylabadlo HE, Memar MY, Mohammadi AB, Ghotaslou R. The synergistic effect of turmeric aqueous extract and chitosan against multidrug-resistant bacteria. New Microbes New Infect. 2021;41:100861.

DOI: 10.1016/j.nmni.2021.100861 PMID: 33898041

17. Cai M, Wang Y, Wang R, Li M, Zhang W, Yu J, et al. Antibacterial and antibiofilm activities of chitosan nanoparticles loaded with Ocimum basilicum L. essential oil. Int J Biol Macromol. 2022;202:122-129.

DOI: 10.1016/j.ijbiomac.2022.01.066 PMID: 35041880

18. Mastoor S, Nazim F, Rizwan-Ul-Hasan S, Ahmed K, Khan S, Ali SN, et al. Analysis of the Antimicrobial and Anti-Biofilm Activity of Natural Compounds and Their Analogues against Staphylococcus aureus Isolates. Molecules. 2022;27(20):6874. DOI: 10.3390/molecules27206874 PMID: 36296467

19. Khaleghian M, Sahrayi H, Hafezi Y, Mirshafeeyan M, Moghaddam ZS, Farasati Far B, et al. In silico design and mechanistic study of niosome-encapsulated curcumin against multidrug-resistant Staphylococcus aureus biofilms. Front Microbiol. 2023;14:1277533. DOI: 10.3389/fmicb.2023.1277533 PMID: 38098658

20. Cerchiara T, Abruzzo A, di Cagno M, Bigucci F, Bauer-Brandl A, Parolin C, et al. Chitosan based micro- and nanoparticles for colon-targeted delivery of vancomycin prepared by alternative processing methods. Eur J Pharm Biopharm. 2015;92:112-9. DOI: 10.1016/j.ejpb.2015.03.004 PMID: 25769679

21. Wayne P. Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing: 35th informational supplement. CLSI document M100-S35. 2025. URL: https://clsi.org/shop/standards/m100

22. Stepanović S, Vuković D, Hola V, Di Bonaventura G, Djukić S, Cirković I, et al. Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS. 2007;115(8):891-9. DOI: 10.1111/j.1600-0463.2007.apm_630.x PMID: 17696944

23. Atshan SS, Shamsudin MN, Karunanidhi A, van Belkum A, Lung LT, Sekawi Z, et al. Quantitative PCR analysis of genes expressed during biofilm development of methicillin resistant Staphylococcus aureus (MRSA). Infect Genet Evol. 2013;18:106-12. DOI: 10.1016/j.meegid.2013.05.002 PMID: 23669446

24. Kashi M, Noei M, Chegini Z, Shariati A. Natural compounds in the fight against Staphylococcus aureus biofilms: a review of antibiofilm strategies. Front Pharmacol. 2024;15:1491363.

DOI: 10.3389/fphar.2024.1491363 PMID: 39635434

25. Costa EM, Silva S, Vicente S, Neto C, Castro PM, Veiga M, et al. Chitosan nanoparticles as alternative anti-staphylococci agents: Bactericidal, antibiofilm and antiadhesive effects. Mater Sci Eng C Mater Biol Appl. 2017;79:221-226.

DOI: 10.1016/j.msec.2017.05.047 PMID: 28629011

26. Tan Y, Ma S, Leonhard M, Moser D, Haselmann GM, Wang J, et al. Enhancing antibiofilm activity with functional chitosan nanoparticles targeting biofilm cells and biofilm matrix. Carbohydr Polym. 2018;200:35-42.

DOI: 10.1016/j.carbpol.2018.07.072 PMID: 30177175

27. Danaei M, Dehghankhold M, Ataei S, Hasanzadeh Davarani F, Javanmard R, Dokhani A, et al. Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems. Pharmaceutics. 2018;10(2):57.

DOI: 10.3390/pharmaceutics10020057 PMID: 29783687

28. Honary S, Zahir F. Effect of Zeta Potential on the Properties of Nano-Drug Delivery Systems - A Review (Part 2). Trop J Pharm Res. 2013;12(2):265–273. DOI: 10.4314/tjpr.v12i2.20

29. Kong M, Chen XG, Xing K, Park HJ. Antimicrobial properties of chitosan and mode of action: a state of the art review. Int J Food Microbiol. 2010;144(1):51-63.

DOI: 10.1016/j.ijfoodmicro.2010.09.012 PMID: 20951455

30. Gayani B, Dilhari A, Wijesinghe GK, Kumarage S, Abayaweera G, Samarakoon SR, et al. Effect of natural curcuminoids-intercalated layered double hydroxide nanohybrid against Staphylococcus aureus, Pseudomonas aeruginosa, and Enterococcus faecalis: A bactericidal, antibiofilm, and mechanistic study. Microbiologyopen. 2019;8(5):e00723.

DOI: 10.1002/mbo3.723 PMID: 30221843

31. Luan L, Chi Z, Liu C. Chinese White Wax Solid Lipid Nanoparticles as a Novel Nanocarrier of Curcumin for Inhibiting the Formation of Staphylococcus aureus Biofilms. Nanomaterials (Basel). 2019;9(5):763.

DOI: 10.3390/nano9050763 PMID: 31109013

32. O'Gara JP. ica and beyond: biofilm mechanisms and regulation in Staphylococcus epidermidis and Staphylococcus aureus. FEMS Microbiol Lett. 2007;270(2):179-88.

DOI: 10.1111/j.1574-6968.2007.00688.x PMID: 17419768

33. Targhi AA, Moammeri A, Jamshidifar E, Abbaspour K, Sadeghi S, Lamakani L, et al. Synergistic effect of curcumin-Cu and curcumin-Ag nanoparticle loaded niosome: Enhanced antibacterial and anti-biofilm activities. Bioorg Chem. 2021;115:105116.

DOI: 10.1016/j.bioorg.2021.105116 PMID: 34333420

34. Ramasamy M, Lee JH, Lee J. Development of gold nanoparticles coated with silica containing the antibiofilm drug cinnamaldehyde and their effects on pathogenic bacteria. Int J Nanomedicine. 2017;12:2813-2828. DOI: 10.2147/IJN.S132784 PMID: 28435260